Hemoglobin and neutrophil levels stratified according to International Metastatic Renal Cell Carcinoma Database Consortium risk predict the effectiveness of ipilimumab plus nivolumab in patients with advanced metastatic renal cell carcinoma.

Nami Tomiyama,Yoshihiko Tasaki,Shuzo Hamamoto,Yosuke Sugiyama,Taku Naiki,Toshiki Etani,Kazumi Taguchi,Nayuka Matsuyama,Yasuhito Sue,Yoshihisa Mimura, Kunihiro Odagiri,Yusuke Noda, Maria Aoki,Yoshinobu Moritoki,Satoshi Nozaki,Satoshi Kurokawa,Atsushi Okada,Noriyasu Kawai,Yoko Furukawa-Hibi,Takahiro Yasui

International journal of urology : official journal of the Japanese Urological Association（2023）

引用 0|浏览9

暂无评分

摘要

Hemoglobin and neutrophil levels may represent crucial biomarkers for predicting the effectiveness of ipilimumab plus nivolumab therapy in patients with renal cell carcinoma.

查看译文

关键词

IMDC, ipilimumab, nivolumab, renal cell carcinoma.

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要